Ion Beratis

Dr. Ion Beratis

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2025 in Psychiatry International
Verified
Journal Article
Open access
PDF file
KGKaterina Gounari Alkisti Gounari
Katerina Gounari Alkisti Gounari
EGEvgenia Giatzoglou
Evgenia Giatzoglou
RKRyan Kemm
Ryan Kemm
IBIon Beratis
Ion Beratis
Chrysanthi NegaChrysanthi Nega
Chrysanthi Nega
Panagiotis KourtesisPanagiotis Kourtesis
Panagiotis Kourtesis
Background: Virtual Reality (VR) is transforming neuropsychological assessment by providing immersive environments that closely replicate real-world conditions. This study presents the Trail Making Test in VR (TMT-VR), a novel adaptation of the traditional TMT, aimed at evaluating cognitive functions in adults with Attention Deficit Hyperactivity Disorder (ADHD). We examined the ecological validity, convergent validity, usability, and user experience of the TMT-VR compared to the traditional version. Methods: Fifty-three adults (18–40 years old), including 25 with ADHD and 28 neurotypical controls, completed both the traditional and VR versions of the TMT. The participants also provided feedback on the VR experience via standardized questionnaires. Results: The statistical analyses demonstrated a significant positive correlation between TMT-VR scores and both the traditional TMT and ADHD symptomatology as measured by the Adult Self-Report Scale, confirming the TMT-VR’s ecological and convergent validity. High usability and positive user experience ratings indicated strong acceptability of the VR platform. Notably, the ADHD group exhibited greater performance differences in the VR environment, suggesting that VR may more effectively capture real-world cognitive challenges. Conclusions: These findings suggest that TMT-VR is a valid, engaging, and ecologically valid tool for cognitive assessment in ADHD and other clinical populations, offering enhanced insights over traditional methods.

25 September 2023 in Geriatrics
Verified
Journal Article
Open access
PDF file
Kleio MoustakaKleio Moustaka
Kleio Moustaka
Chrysanthi NegaChrysanthi Nega
Chrysanthi Nega
IBIon Beratis
Ion Beratis
The present study aims to explore the differences in the manifestation of cognitive decline and psychiatric symptoms across the different ages of MCI onset: early onset (EOMCI: 75 years old). It was hypothesized that individuals with EOMCI will preserve their cognitive functions to a greater extent as compared to individuals with LOMCI, even after adjusting the cognitive performance for age and education through the use of published Greek norms. The level of cognitive decline concerning MOMCI was evaluated for extracting more precise conclusions regarding the impact of the age of onset on the patterns of MCI symptomatology. The analyses of data were conducted in a Greek population of individuals with MCI, who were consecutive visitors of the Outpatient Memory Clinic of Nestor Alzheimer’s Centre in Athens, Greece. The sample consisted of 297 participants who fulfilled the following inclusion criteria: MCI diagnosis based on Petersen’s criteria, Greek mother language, and absence of a psychiatric history or chronic and incurable organic disease. The overall results support the presence of a cognitive advantage of the EOMCI group compared to the LOMCI group. In the MOMCI group, cognitive performance displayed a tendency to remain intermediate compared to the other two groups. Nonetheless, significant differences were observed when this group was compared with the LOMCI group. The current findings indicate that the age of onset should be taken under consideration in the neuropsychological assessment of individuals with MCI. The specific parameters could have implications in terms of prognosis as well as the design and implementation of tailored interventions.

16 March 2023 in Geriatrics
Verified
Journal Article
Open access
PDF file
MMMichalis Mougias
Michalis Mougias
IBIon Beratis
Ion Beratis
Kleio MoustakaKleio Moustaka
Kleio Moustaka
Panagiotis AlexopoulosPanagiotis Alexopoulos
Panagiotis Alexopoulos
KAKonstantinos Assimakopoulos
Konstantinos Assimakopoulos
The objective of the present work was to compare the levels of executive, emotional, and initiation apathy in individuals with mild cognitive impairment (MCI), mild Alzheimer’s disease dementia (ADD), and cognitively intact healthy controls (HCs). Fifty-two patients with mild ADD, 40 individuals with MCI, and 37 cognitively intact individuals were included in the current study. The participants were consecutive visitors to the Outpatient Memory Clinic of “Nestor” Alzheimer’s Center. The symptoms of apathy were measured with the dimensional apathy scale. Analyses showed that ADD patients had significantly higher degrees of executive, emotional, initiation, and overall apathy compared with both the MCI group and the HCs. Additionally, a significant difference was observed in the dimension of executive apathy between individuals with MCI and the HCs. In conclusion, the dimension of executive apathy was the most sensitive measure regarding the differentiation of individuals with mild ADD or MCI and HCs. Hence, detailed evaluation of executive apathy in older individuals referred to a memory clinic may provide useful information contributing to their diagnostic categorization and to the differentiation between neurocognitive disorders and healthy cognitive ageing.

20 December 2022 in Geriatrics
Verified
Journal Article
Open access
PDF file
VPVicky Papastefanopoulou
Vicky Papastefanopoulou
EVANGELIA STANITSAEVANGELIA STANITSA
EVANGELIA STANITSA
CKChristos Koros
Christos Koros
ASAimilios Christos Simoudis
Aimilios Christos Simoudis
CFChryseis Florou-Hatziyiannidou
Chryseis Florou-Hatziyiannidou
SPSokratis G. Papageorgiou
Sokratis G. Papageorgiou
Background: the apolipoprotein e4 allele (APOE4) constitutes an established genetic risk factor for Alzheimer’s Disease Dementia (ADD). We aimed to explore the frequency of the APOE isoforms in the Greek population of Southern Greece. Methods: peripheral blood from 175 Greek AD patients, 113 with mild cognitive impairment (MCI), and 75 healthy individuals. DNA isolation was performed with a High Pure PCR Template Kit (Roche), followed by amplification with a real-time qPCR kit (TIB MolBiol) in Roche’s Light Cycler PCR platform. Results: APOE4 allele frequency was 20.57% in the ADD group, 17.69% in the MCI group, and 6.67% in the control group. APOE3/3 homozygosity was the most common genotype, while the frequency of APOE4/4 homozygosity was higher in the AD group (8.60%). APOE4 carrier status was associated with higher odds for ADD and MCI (OR: 4.49, 95% CI: [1.90–10.61] and OR: 3.82, 95% CI: [1.59–9.17], respectively). Conclusion: this study examines the APOE isoforms and is the first to report a higher APOE frequency in MCI compared with healthy controls in southern Greece. Importantly, we report the occurrence of the APOE4 allele, related to ADD, as amongst the lowest globally reported, even within the nation, thus enhancing the theory of ethnicity and latitude contribution.

17 September 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
KGKaterina Gounari Alkisti Gounari
Katerina Gounari Alkisti Gounari
EGEvgenia Giatzoglou
Evgenia Giatzoglou
RKRyan Kemm
Ryan Kemm
IBIon Beratis
Ion Beratis
Chrysanthi NegaChrysanthi Nega
Chrysanthi Nega
Panagiotis KourtesisPanagiotis Kourtesis
Panagiotis Kourtesis
Background: Virtual Reality (VR) is transforming neuropsychological assessment by providing immersive environments that closely replicate real-world conditions. This study presents the Virtual Reality Trail Making Test (TMT-VR), a novel adaptation of the traditional Trail Making Test, aimed at evaluating cognitive functions in individuals with Attention Deficit Hyperactivity Disorder (ADHD). We examined the ecological validity, convergent validity, usability, and user experience of the TMT-VR compared to the traditional version. Methods: Fifty-three participants, including 25 with ADHD and 28 neurotypical controls, completed both the traditional and VR versions of the TMT. Participants also provided feedback on the VR experience via standardized questionnaires. Results: Statistical analyses demonstrated a significant positive correlation between TMT-VR scores and both the traditional TMT and ADHD symptomatology as measured by the Adult Self-Report Scale (ASRS), confirming the TMT-VR’s ecological and convergent validity. High usability and positive user experience ratings indicated strong acceptability of the VR platform. Notably, the ADHD group exhibited greater performance differences in the VR environment, suggesting that VR may more effectively capture real-world cognitive challenges. Conclusions: These findings suggest that TMT-VR is a valid, engaging, and ecologically valid tool for cognitive assessment in ADHD, and other clinical populations, offering enhanced insights over traditional methods.

14 February 2025 in medRxiv
Verified
Preprint
Open access
PDF file
Chrysanthi NegaChrysanthi Nega
Chrysanthi Nega
Kleio MoustakaKleio Moustaka
Kleio Moustaka
IBIon Beratis
Ion Beratis
The present study aims to explore the impact of neuropsychiatric symptoms, cognitive functioning, and medical status on sleep problems in individuals with Mild Cognitive Impairment (MCI), focusing on insomnia, by implementing a latent variable approach. The 131 Greek patients with MCI, who are consecutive visitors of the Alzheimer’s day clinic, underwent comprehensive assessments in cognitive functioning, neuropsychiatric symptoms, sleeping disturbances, and medical health status. The model was estimated by applying a Partial Least Squares (PLS) approach to structural equation modeling (SEM), incorporating the following latent variables: “psychological burden” (3 indicators: depressive symptoms, anxiety, and stress), “cognitive status” (5 indicators: general cognitive status, phonemic and semantic fluencies, psychomotor speed, and episodic memory), and “sleep problems” (5 indicators: overnight and earlier final awakening(s), decreased daytime functioning and well-being, and insufficient sleep duration). The results supported the SEM effectiveness, with good model fit and high predictive power. The “psychological burden” played the most significant role in the development of sleep problems within the clinical group of MCI, while “cognitive status” appeared to be the second most important SEM predictor, showing a negative association with “sleep problems”. Additionally, MCI age of onset and sleep problems severity were negatively associated. This latent-variable approach allowed us to capture the multidimensional complexity of sleep problems in MCI. Thus, applying integrative evaluations and interventions that target the cognitive status and psychological well-being, may improve the sleep quality of individuals with MCI, and further contribute to a slower cognitive decline course.